Resnik Robert
University of California, San Diego School of Medicine, La Jolla, California 92093-0621, USA.
Obstet Gynecol. 2002 Mar;99(3):490-6. doi: 10.1016/s0029-7844(01)01780-x.
Fetal intrauterine growth restriction presents a complex management problem for the clinician. The failure of a fetus to achieve its growth potential imparts a significantly increased risk of perinatal morbidity and mortality. Consequently, the obstetrician must recognize and accurately diagnose inadequate fetal growth and attempt to determine its cause. Growth aberrations, which are the result of intrinsic fetal factors such as aneuploidy and multifactorial congenital malformations, and fetal infection, carry a guarded prognosis. However, when intrauterine growth restriction is caused by placental abnormalities or maternal disease, the growth aberration is usually the consequence of inadequate substrates for fetal metabolism and, to a greater or lesser degree, decreased oxygen availability. Careful monitoring of fetal growth and well-being, combined with appropriate timing and mode of delivery, can best ensure a favorable outcome. Ultrasound evaluation of fetal growth, behavior, and measurement of impedance to blood flow in fetal arterial and venous vessels form the cornerstone of evaluation of fetal condition and decision making.
胎儿宫内生长受限给临床医生带来了复杂的管理难题。胎儿未能发挥其生长潜能会显著增加围产期发病率和死亡率。因此,产科医生必须识别并准确诊断胎儿生长不足,并试图确定其原因。由胎儿内在因素如非整倍体和多因素先天性畸形以及胎儿感染导致的生长异常,预后不佳。然而,当宫内生长受限由胎盘异常或母体疾病引起时,生长异常通常是胎儿代谢底物不足以及在或大或小程度上氧供应减少的结果。仔细监测胎儿生长和健康状况,结合适当的分娩时机和方式,能最好地确保良好结局。对胎儿生长、行为进行超声评估以及测量胎儿动脉和静脉血管中的血流阻抗,构成了评估胎儿状况和决策的基石。